To include your compound in the COVID-19 Resource Center, submit it here.

House judiciary subcommittee holds hearing on sovereign immunity

Four IP and law experts testified to a House judiciary subcommittee on Tuesday concerning the use of sovereign immunity to shield patents from inter partes review (IPR). The hearing was prompted by the actions of Allergan plc (NYSE:AGN), which in September transferred six patents covering the dry eye drug Restasis cyclosporine to the Saint Regis Mohawk Tribe. The tribe in turn filed a motion requesting that the Patent Trial and Appeal Board (PTAB) dismiss petitions from three generic drug companies that are trying to use IPRs to invalidate the patents

Read the full 901 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE